Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer

被引:5
|
作者
Kuroda, Kenji [1 ]
Tasaki, Shinsuke [1 ]
Sato, Akinori [1 ]
Asakuma, Junichi [1 ]
Horiguchi, Akio [1 ]
Ito, Keiichi [1 ]
机构
[1] Natl Def Med Coll, Dept Urol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan
关键词
bladder cancer; continuous saline bladder irrigation; non-muscle-invasive bladder cancer; intravesical recurrence; IMMEDIATE POSTOPERATIVE INSTILLATION; PROGRESSION; GUIDELINES; RISK;
D O I
10.3892/mco.2020.2079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A single immediate instillation of chemotherapy following transurethral resection of bladder tumor (TURBT) is effective in preventing intravesical recurrence (IVR) in patients with non-muscle-invasive urothelial bladder carcinoma (NMIBC). However, continuous saline bladder irrigation (CSBI) is also performed with a single instillation of chemotherapy (SIC), but its inhibitory effect on IVR remains unclear. In the present study, the effect of CSBI with concomitant SIC following TUR on IVR was evaluated in patients with NMIBC. A retrospective review of 253 patients who underwent TURBT and were clinically and histologically diagnosed with NMIBC at National Defense Medical College Hospital was performed. Doxorubicin (DXR) was administered to all patients. Methods of DXR administration included a single instillation of DXR (60 mg in 30-40 ml saline) in 34 patients (group A), continuous irrigation of the bladder with saline including DXR (80 mg in 1 liter saline) in 40 patients (group B) and overnight CSBI after a single instillation of DXR in 179 patients (group C). The difference in IVR-free survival rates was compared after adjusting for significant differences in several covariates between the groups by nearest-neighbor propensity score matching. Prior to propensity score matching, it was identified that time to IVR was significantly longer in group A than in groups B and C; however, it was observed that several factors significantly differed among the three groups. By using nearest neighbor matching, 18 pairs were matched between groups A and B and 33 pairs between the groups A and C. No significant difference was identified in any covariates between these two matched group pairsTime to IVR was significantly longer in the matched group A than in the matched groups B and C (P=0.0255 and P=0.0023, respectively). In conclusion, SIC alone could provide a higher IVR-free survival rate than CSBI with DXR or CSBI with SIC.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] Impact of secondary transurethral resection on recurrence rates in patients with non-muscle-invasive bladder cancer
    Khalmurzaev, O. A.
    Matveev, V. B.
    Peterson, S. B.
    Romanov, V. A.
    Panakhov, A. D.
    Khailenko, A. V.
    ONKOUROLOGIYA, 2012, 8 (02): : 66 - 71
  • [22] Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation
    Sun, Jian-Xuan
    An, Ye
    Xu, Meng-Yao
    Liu, Chen-Qian
    Xu, Jin-Zhou
    Xia, Qi-Dong
    Wang, Shao-Gang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors
    Zhongbao Zhou
    Shikai Zhao
    Youyi Lu
    Jitao Wu
    Yongwei Li
    Zhenli Gao
    Diandong Yang
    Yuanshan Cui
    World Journal of Urology, 2019, 37 : 1075 - 1084
  • [24] Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    EUROPEAN UROLOGY FOCUS, 2018, 4 (04): : 503 - 505
  • [25] Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C
    Andrew T. Lenis
    Kian Asanad
    Maher Blaibel
    Nicholas M. Donin
    Karim Chamie
    BMC Urology, 18
  • [26] Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer
    Gondran-Tellier, B.
    Abdallah, R.
    Sichez, P. C.
    Akiki, A.
    Toledano, H.
    Gaillet, S.
    Delaporte, V
    Karsenty, G.
    Bastide, C.
    Daniel, L.
    Garcia, S.
    Rossi, D.
    Lechevallier, E.
    Boissier, R.
    Baboudjian, M.
    PROGRES EN UROLOGIE, 2021, 31 (06): : 316 - 323
  • [27] Clinical efficacy of intravesical gemcitabine combined with ubenimex in patients with non-muscle-invasive bladder carcinoma after transurethral resection of bladder tumor
    Shao, Li-Jun
    Wang, Hai-Jiang
    Wang, Jia-Rong
    Yuan, Xiao-Fei
    Sha, Quan
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05) : 1243 - 1249
  • [28] Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer
    Ahmadi, Niloufar
    Shafee, Hamid
    Moudi, Emaduddin
    ASIAN JOURNAL OF UROLOGY, 2024, 11 (04) : 625 - 632
  • [29] The treatment of non-muscle-invasive bladder cancer with intravesical chemotherapy and immunotherapy
    Whelan, Peter
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (08) : 568 - 571
  • [30] Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour
    Suarez-Ibarrola, Rodrigo
    Soria, Francesco
    Abufaraj, Mohammad
    D'Andrea, David
    Preto, Mirko
    Gust, Kilian M.
    Briganti, Alberto
    Shariat, Shahrokh F.
    Gontero, Paolo
    BJU INTERNATIONAL, 2019, 123 (04) : 646 - 650